Advisors Preferred, LLC Incyte Corp Transaction History

Advisors Preferred, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$68.67 - $84.02 $682,717 - $835,326	-9,942 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$79.87 - $87.53 $794,067 - $870,223	9,942 New	9,942 $835,000
Q2 2020 Aug 11, 2020	SELL	$74.18 - $108.93 $69,803 - $102,503	-941 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$63.18 - $85.97 $59,452 - $80,897	941 New	941 $69,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.